4//SEC Filing
MacLean Michael F 4
Accession 0001599901-24-000188
CIK 0001599901other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 4:50 PM ET
Size
16.3 KB
Accession
0001599901-24-000188
Insider Transaction Report
Form 4
MacLean Michael F
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-11-06$46.22/sh−27,262$1,260,017→ 94,093 total - Exercise/Conversion
Common Stock
2024-11-06$6.57/sh+13,875$91,159→ 107,968 total - Sale
Common Stock
2024-11-06$45.33/sh−13,875$629,008→ 94,093 total - Exercise/Conversion
Common Stock
2024-11-06$8.82/sh+65,182$574,905→ 159,275 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-11-06−65,182→ 0 totalExercise: $8.82Exp: 2030-05-14→ Common Stock (65,182 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-11-06−13,875→ 60,125 totalExercise: $6.57Exp: 2033-09-10→ Common Stock (13,875 underlying) - Sale
Common Stock
2024-11-06$45.33/sh−65,182$2,954,954→ 94,093 total
Footnotes (5)
- [F1]The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on July 8, 2024.
- [F2]This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.86 to $48.01. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.88 to $48.01. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]All shares subject to this option have fully vested as of the date of this report.
- [F5]1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of September 11, 2023 (the "Vesting Commencement Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the option shall be fully vested on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
Avidity Biosciences, Inc.
CIK 0001599901
Entity typeother
Related Parties
1- filerCIK 0001383731
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 4:50 PM ET
- Size
- 16.3 KB